iPhone app iPad app Android phone app Android tablet app

Pharma

Zach Carter

10 Ways Obama, Congress Could Cut U.S. Budget Without Raising Income Taxes Or Slashing Entitlements

HuffingtonPost.com | Zach Carter | Posted 11.30.2012 | Politics

WASHINGTON -- Just about every policy lawmakers are considering for a deal to avert the so-called fiscal cliff would involve either raising individual...

A Defense of the Private Sector

Nathan Risinger | Posted 01.08.2013 | World
Nathan Risinger

Simply to dismiss the private sector out of hand would be a mistake for the global public health field. Private companies play a pivotal role in public health issues. It is only through a marriage of the public and the private that we can see effective change in health issues across the globe.

Zach Carter

Obama Administration Says 'No' To Global Health Fund For Developing Nations

HuffingtonPost.com | Zach Carter | Posted 05.25.2012 | Politics

WASHINGTON -- The Obama administration has alarmed global health experts by opposing a new international fund that would fight disease in the developi...

Lethal injection drug access could put executions on hold

The Center for Public Integrity | Posted 06.04.2012 | Politics
The Center for Public Integrity

By Kimberly Leonard, iWatch NewsA federal judge's decision to block imports of a drug used in executions will leave states to rely more on a substit...

Part II: Antibiotics Injected Directly Into Eggs and Other Big Pharma Secrets

Martha Rosenberg | Posted 04.18.2012 | Healthy Living
Martha Rosenberg

It was not a great surprise that the FDA's new cephalosporin livestock rules have the Agribusiness Seal of Approval. It was Big Pharma and Agribusiness lobbying that killed its stronger cephalosporin rules issued four years after.

Zach Carter

Congress Threatens Foundation Of Internet

HuffingtonPost.com | Zach Carter | Posted 12.16.2011 | Politics

Ryan Grim contributed reporting WASHINGTON -- A month ago, Google lobbyist Katherine Oyama absorbed one of the more unusual congressional tongue-la...

7 Diseases Big Pharma Hopes You Get in 2012

Martha Rosenberg | Posted 02.13.2012 | Healthy Living
Martha Rosenberg

It used to be joked that a consultant is someone who borrows your watch to tell you what time it is. These days, the opportunist is Big Pharma, which raises your insurance premiums and taxes while providing you "low-priced" drugs that you paid for.

It's the Century of Biology: Are the Candidates Listening?

Jonathan D. Moreno | Posted 02.05.2012 | Politics
Jonathan D. Moreno

So far in this election cycle, the only vaguely relevant recognition of the importance of leadership in biotechnology for the country's future was a polemical and uninformative exchange on vaccination policy.

Zach Carter

ERROR 404: Congress Wants To Break The Internet

HuffingtonPost.com | Zach Carter | Posted 11.17.2011 | Politics

WASHINGTON -- At a House Judiciary Committee hearing Wednesday, Democrats and Republicans joined together to voice support for legislation that would ...

Zach Carter

Big Pharma Wins, AIDS Patients Lose In New Trade Deal

HuffingtonPost.com | Zach Carter | Posted 12.05.2011 | Politics

This piece is a continuation of The Huffington Post's collaboration on trade issues with The Dylan Ratigan Show, called Trading Our Future. WASHING...

Obama and Perry Stop Folking America

Mark Steinberg | Posted 11.14.2011 | Comedy
Mark Steinberg

A quick read of President Obama's 4,000 word jobs speech to Congress on September 8 reveals that he has apparently decided there are no folks in Ame...

Zach Carter

THE SPOILSMEN COMETH: How Congress Corrupted Patent Reform

HuffingtonPost.com | Zach Carter | Posted 10.04.2011 | Politics

WASHINGTON -- After months of dead-end negotiations over raising the federal debt ceiling, President Barack Obama walked into the East Room of the Whi...

Ryan Grim

Democrats Turning On Big Pharma In Debt Debate

HuffingtonPost.com | Ryan Grim | Posted 09.07.2011 | Politics

WASHINGTON -- Democrats have targeted pharmaceutical profits as a means of raising revenue as part of the debt ceiling deal, Rep. Chris Van Hollen (D-...

How Does A $214 Million Earmark Gets Votes From Paul, Bachmann?

Roll Call | John Stanton | Posted 08.29.2011 | Politics

How does a policy earmark worth more than $214 million garner the votes of conservatives such as GOP Reps. Michele Bachmann (Minn.) and Ron Paul (Texa...

"Med Schools Flunk at Keeping Faculty Off Pharma Speaking Circuit"

Craig Newmark | Posted 05.25.2011 | Home
Craig Newmark

Hey, the folks at ProPublica do true public service media, funded philanthropically and according to a strict code of ethics. The code is a really big...

Obama in India

James Love | Posted 05.25.2011 | World
James Love

A number of NGOs working on public health issues are concerned that the President may push India to adopt more strict intellectual property protections on pharmaceutical drugs. They have reasons to be concerned.

How Big Pharma's Demise Has Been Greatly Exaggerated

Dr. Jeffrey H. Toney | Posted 05.25.2011 | Home
Dr. Jeffrey H. Toney

The pharmaceutical industry relies predominately upon patent protection of intellectual property to yield profits that are critical to support research and development, but there are exceptions that demonstrate the value of open innovation.

GE Ignored Omniscan Safety Advice And May Have Hid Evidence From FDA, Documents Show

ProPublica | Jeff Gerth | Posted 05.25.2011 | Business

GE Healthcare ignored the advice of its own safety experts to "proactively" restrict use of its imaging drug, Omniscan, after reports in Europe linked...

Big Pharma Wins Big With Health Care Reform Bill

AP | ALAN FRAM | Posted 05.25.2011 | Politics

WASHINGTON — Chalk one up for the pharmaceutical lobby. The U.S. drug industry fended off price curbs and other hefty restrictions in President ...

Is Medicare Part D A Bait And Switch?

Francine Hardaway | Posted 11.17.2011 | Healthy Living
Francine Hardaway

In this deal, Medicare Part D (prescription drug benefit) was passed with a right of the pharmaceutical companies to raise drug prices during the open enrollment period.

Billy Tauzin Leaving Pharma: Top Lobbyist For Drugmakers Stepping Down

AP | ERICA WERNER | Posted 05.25.2011 | Politics

WASHINGTON — The head of the influential trade association for drug manufacturers announced Thursday night that he is leaving his job. The deve...

Ryan Grim

Nelson Ready To Bust Pharma Deal: 'They Need 60 Votes, Don't They?'

HuffingtonPost.com | Ryan Grim | Posted 05.25.2011 | Politics

Sen. Bill Nelson, a Florida Democrat, said on Sunday that if leadership doesn't work with him on his amendment that would break the White House deal w...

Health Care Bill's Winners And Losers: Drug Makers To Benefit, Insurers Brace For Hit

Wall Street Journal | JANET ADAMY and GREG HITT | Posted 05.25.2011 | Politics

The drug industry stands to gain in a health-care overhaul by getting tens of millions of newly insured customers, while insurance companies -- especi...

Big Pharma Deal May Be Cut Back By Last-Minute Progressive Resistance

New York Times | DAVID D. KIRKPATRICK | Posted 05.25.2011 | Politics

Facing last-minute liberal resistance in Congress, the drug industry is bracing for an increase in its share of the cost of the proposed health care o...

GOP Health Bill In The Works; Boehner Says Republican Bill Would Extend Insurance Coverage To "Millions"

Wall Street Journal | GREG HITT | Posted 05.25.2011 | Politics

Republicans are preparing an alternative health-care bill to Democratic legislation, House Republican Leader John Boehner said, marking a shift in str...